Södertälje, Sweden

Nils A Jonsson

This inventor holds 4 USPTO granted patents. Top assignees: Ab Kabi, Pharmacia Aktiebolag. Active years: 1978-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nils A Jonsson. Retrieved from https://idiyas.com/inventor/nils-a-jonsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 1978-1995

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Nils A Jonsson: Innovator in Pharmaceutical Chemistry

Introduction

Nils A Jonsson is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of four patents. His work primarily focuses on the development of novel compounds with potential therapeutic applications.

Latest Patents

Among his latest patents, Jonsson has developed 3,3-diphenylpropylamines and pharmaceutical compositions thereof. This invention includes a range of compounds characterized by specific structural formulas, which have applications as drugs, particularly as anticholinergic agents. Additionally, he has created pharmacodynamically active indan derivatives, which encompass new compounds and their corresponding amine oxides, quaternary ammonium compounds, and salts with physiologically acceptable acids.

Career Highlights

Throughout his career, Nils A Jonsson has worked with prominent companies in the pharmaceutical industry, including Ab Kabi and Pharmacia Aktiebolag. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Jonsson has collaborated with notable colleagues such as Lembit Mikiver and Pinchas Moses, further enhancing his contributions to the field of pharmaceutical research.

Conclusion

Nils A Jonsson's innovative work in pharmaceutical chemistry has led to the development of important compounds with potential medical applications. His patents reflect a commitment to advancing drug discovery and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…